These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7325404

  • 1. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P, Pagratis N.
    Angiology; 1981 Oct; 32(10):679-85. PubMed ID: 7325404
    [No Abstract] [Full Text] [Related]

  • 2. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F, Perbellini A, Adami CA, Dal Cortivo G, Bucci S.
    Clin Ter; 1986 Dec 15; 119(5):379-85. PubMed ID: 2951055
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V.
    Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536
    [No Abstract] [Full Text] [Related]

  • 4. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S, Manganaro A, Barbera MC, Cento D, Buda D, Arrigo F, Consolo F.
    Minerva Cardioangiol; 1986 Nov 30; 34(11):745-9. PubMed ID: 2949163
    [No Abstract] [Full Text] [Related]

  • 5. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug 30; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 6. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]

  • 7. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
    Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R.
    J Int Med Res; 1985 Mar 02; 13(6):317-21. PubMed ID: 4076530
    [Abstract] [Full Text] [Related]

  • 8. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F, Briguglio E, Di Marco V, Swat M, Materia G, Intilisano A.
    J Int Med Res; 1986 Mar 02; 14(3):115-23. PubMed ID: 3721052
    [Abstract] [Full Text] [Related]

  • 9. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R, Klaus D.
    Vasa; 1984 Mar 02; 13(2):171-4. PubMed ID: 6741240
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

  • 12. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G, Rotatori P, Gaggi S, Barone A, Pupita F.
    Minerva Cardioangiol; 1988 Jun 24; 36(6):319-22. PubMed ID: 3211330
    [No Abstract] [Full Text] [Related]

  • 13. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S, Ferulano GP, Vanni L, Dilillo S, Picilli M, D'Alessio E.
    Minerva Cardioangiol; 1985 Nov 24; 33(11):749-56. PubMed ID: 2935748
    [No Abstract] [Full Text] [Related]

  • 14. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T.
    J Int Med Res; 1984 Nov 24; 12(3):188-92. PubMed ID: 6734922
    [No Abstract] [Full Text] [Related]

  • 15. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V, Mammarella A, Alessandrini A, Barlattani M.
    Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN, Potortì F, Urbano O, Perroni GB.
    Minerva Cardioangiol; 1988 May 15; 36(5):249-52. PubMed ID: 3059229
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
    Marci M, Albiani B, Ricci M, Russo F.
    Clin Ter; 1995 Mar 15; 146(3):211-4. PubMed ID: 7789083
    [Abstract] [Full Text] [Related]

  • 18. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J, Intaglietta M, Messmer K.
    Fortschr Med; 1982 Nov 04; 100(41):1926-30. PubMed ID: 7152426
    [Abstract] [Full Text] [Related]

  • 19. Effect of buflomedil chlorhydrate on local oxygen delivery in peripheral vascular disease.
    Mannarino E, Pasqualini L, Maragoni G, Orlandi U.
    Angiology; 1989 Jun 04; 40(6):559-62. PubMed ID: 2719340
    [Abstract] [Full Text] [Related]

  • 20. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G, Baldoni F, Peruzzi G, Raimondi G, Grimaldi I, Visigalli G, Gristina S, Massaro M, De Martinis L, Sangiorgi M.
    Cardiologia; 1983 Aug 04; 28(8):651-60. PubMed ID: 6687209
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.